Investing With IBD cover image

Ep. 195: Jim Roppel: Stock Market Lessons Of 2022

Investing With IBD

00:00

Amgen Breaks Below Its Beautiful Digestive

I think Amgen needs to be watched very carefully. biotech and semis are really the only growth areas that have any power. And it's not, you know, although we're in a short and maybe intermediate term uptrend, it's lethargic. It's mucky.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app